摘要：编者按:2024年11月15日，第四届亚洲肿瘤学大会在中国西安盛大开幕。本次大会与2024年中国整合肿瘤学大会同期举行，由中国抗癌协会和亚洲肿瘤学会（AOS）共同主办，以“整合与现代”为主题，吸引了亚洲各国肿瘤学专家齐聚一堂，共探癌症防控新策略与临床实践新进展
编者按:2024年11月15日，第四届亚洲肿瘤学大会在中国西安盛大开幕。本次大会与2024年中国整合肿瘤学大会同期举行，由中国抗癌协会和亚洲肿瘤学会（AOS）共同主办，以“整合与现代”为主题，吸引了亚洲各国肿瘤学专家齐聚一堂，共探癌症防控新策略与临床实践新进展。会议期间，《肿瘤瞭望消化时讯》有幸专访到AOS秘书长、韩国首尔国立大学医院Han Kwang Yang教授，探讨亚洲肿瘤学会的使命与未来愿景。以下是采访内容整理，以飨读者！
肿瘤瞭望消化时讯：作为AOS的秘书长，您在本次大会开幕式中介绍了金进博（Jin-Pok Kim）纪念奖的历史背景。能否谈谈您对这一奖项的深刻理解及其重要意义？
Han Kwang Yang教授：Jin-Pok Kim教授是亚洲胃癌手术及肿瘤学领域的杰出先驱。他是我的导师，因此，我深知他在这一领域所做出的巨大贡献。Kim教授不仅是胃癌手术精湛的专家，更是一位具有远见卓识的领导者。
他深信通过汇聚来自不同大学和机构的优秀人才，能够增进多样性并促进学术交流。他始终强调，年轻临床医生应保持科研热情，并熟练掌握包括英语在内的多种沟通技巧，以便更好地参与全球合作。
在Kim教授的积极推动下，韩国癌症协会、亚太抗癌组织联盟（APFOCC）以及亚洲临床肿瘤学会相继成立，为肿瘤学领域的合作铺平了道路。我们今天所庆祝的亚洲肿瘤学会（AOS）正是这些机构于2018年合并而成的产物，它充分体现了Kim教授在推动癌症研究与治疗方面所倡导的“团结与合作”的愿景。
Prof. Han-Kwang Yang: Professor Jin-Pok Kim was a pioneering figure in gastric cancer surgery and oncology across Asia. Personally, he was also my mentor, so I deeply understand his immense contributions. Professor Kim was not only a skilled surgeon specializing in gastric cancer but also an exceptional leader.
He believed in fostering diversity by bringing together individuals from different universities and institutions. He emphasized the importance of young clinicians being scientifically active and proficient in communication skills, including English, to facilitate global collaboration.
Professor Kim's initiatives led to the establishment of the Korean Cancer Association, the Asian Pacific Cancer Congress, and the Asian Clinical oncology Society, paving the way for collaborative efforts in oncology. The Asian Oncology Society (AOS), which we are celebrating today, was formed in 2018 through the merging of these institutions, embodying his vision of unity and cooperation in advancing cancer research and care.
肿瘤瞭望消化时讯：您在开幕式上发表的主题演讲《我们如何携手共抗胃癌》令人印象深刻。可否简要概述一下您的主要观点和建议？
Han Kwang Yang教授：胃癌仍然是全球范围内一个重大的健康问题，每年约有100万例新发病例，其中近半数发生在亚洲。在首尔国立大学医院，我们专注于采用多学科综合诊疗模式来进行胃癌的治疗。
对于局部胃癌，手术仍然是治疗的核心。然而，对于晚期胃癌，化疗等辅助治疗手段至关重要。管理这种疾病需要放射科医生、消化内科医生、病理医生、外科医生以及包括护士、药剂师和营养师在内的支持团队之间的紧密合作。
除了医院内部的努力外，国际合作也至关重要。我们合作开展的临床试验和研究网络为治疗进展提供了世界级的证据，例如《腹腔镜胃癌手术操作指南》。通过这些努力，我们不断突破胃癌管理的界限。
Prof. Han-Kwang Yang: Gastric cancer remains a significant global health issue, with approximately one million new cases annually, nearly half of which occur in Asia. At Seoul National University Hospital, we specialize in gastric cancer treatment, which involves a multidisciplinary approach.
For localized gastric cancer, surgery remains the cornerstone of treatment. However, for advanced cases, additional therapies such as chemotherapy are essential. Managing this disease requires collaboration among radiologists, gastroenterologists, pathologists, surgeons, and support teams, including nurses, pharmacists, and nutritionists.
Beyond institutional efforts, international cooperation is critical. Our collaborative clinical trials and research networks have provided world-class evidence for treatment advancements, such as laparoscopic surgery guidelines. Through these efforts, we continue to push the boundaries of gastric cancer management.
肿瘤瞭望消化时讯：对于AOS大会的未来，业内充满期待。AOS在推动全球肿瘤学领域的合作与交流方面有哪些具体规划和目标？
Han Kwang Yang教授：尽管美国临床肿瘤学会（ASCO）和欧洲肿瘤内科学会（ESMO）等全球知名的肿瘤学会长期以来一直引领着行业发展，但是，当前亚洲加强自身的合作平台已刻不容缓。众多亚洲临床医生和研究人员在参与国际会议时，常需克服旅途劳顿和时差等重重挑战。
这一认识促成了2018年亚洲肿瘤学会（AOS）的成立，该学会整合了APFOCC和亚洲临床肿瘤学会（ACOS）。自成立以来，我们已成功在马尼拉、首尔、横滨等地举办了多场会议，而今，这一盛会移师西安。在现任主席樊代明院士的卓越领导下，我们正全力将AOS打造成为亚洲肿瘤学家和科学家交流互动的重要平台。
借助亚洲肿瘤学会这一桥梁，我们能够在胃癌等特定疾病高发区域，特别是日本、中国和韩国之间，促进更紧密的合作。亚洲国家地理上的邻近使得更频繁和有意义的交流变得更加容易，这种交流既可以通过线下面对面的会议，也可以借助虚拟会议的形式。这一不断壮大的平台，必将推动亚洲乃至全球肿瘤学领域的持续进步与发展。
Prof. Han-Kwang Yang: While prestigious oncology societies like ASCO in the United States and ESMO in Europe have long served as global leaders, it's time for Asia to strengthen its own collaborative platforms. Many Asian clinicians and researchers face challenges such as travel and jet lag when attending conferences abroad.
This realization led to the creation of the Asian Oncology Society (AOS) in 2018, merging the Asian Pacific Cancer Congress (APCC) and the Asian Clinical Oncology Society (ACOS). Since then, we've hosted successful meetings in Manila, Seoul, Yokohama, and now Xi'an. With the strong leadership of our current president, Dr. Daiming Fan, we aim to build AOS into a vital platform for Asian oncologists and scientists.
Through AOS, we can foster collaboration in areas where diseases like gastric cancer are prevalent, particularly among Japan, China, and Korea. The geographic proximity of Asian countries facilitates more frequent and meaningful interactions, supported by both in-person and virtual meetings. This growing platform will drive advancements in oncology across the region and beyond.
来源：肿瘤瞭望消化时讯